| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.0002 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.0002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.0004 |